Skip to content
Screener

Opko Health OPK Treasury Stock

Treasury Stock at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$5.17B+8.4%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$10M+25.1%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$43.5B-0.2%
Merck & Co. logo
Merck & Co.MRK
$64.13B+6.0%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$1.02B-0.9%
P/S1.7×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
Line itemJune 30, 2026December 31, 2025
Total liabilities645,287663,985
Equity:
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 776,128,402 and 789,917,433 shares issued at June 30, 2026 and December 31, 2025, respectively7,7627,900
Treasury Stock - 30,174,907, and 30,849,907 shares at June 30, 2026 and December 31, 2025, respectively(2,363)(3,176)
Additional paid-in capital3,561,1143,574,942
Accumulated other comprehensive loss(28,393)(21,017)
Accumulated deficit(2,353,954)(2,290,690)
Total shareholders’ equity1,184,1661,267,959

Item 1. Financial Statements

FAQ

What is Opko Health's treasury stock?
Opko Health (OPK) reported treasury stock of $2.36M in Q2 2026.
How has Opko Health's treasury stock changed year-over-year?
Opko Health's treasury stock increased by 31.9% year-over-year, from $1.79M to $2.36M.
What is the long-term trend for Opko Health's treasury stock?
Over 5 years (2020 to 2025), Opko Health's treasury stock has grown at a 12.1% compound annual growth rate (CAGR), from $1.79M to $3.18M.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.

Ask your AI about Opko Health's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude